SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis

This investigation was aimed at disclosing whether SRPX2 affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling.

Detalhes bibliográficos
Main Authors: Gao Zhenyuan, Wu Jisong, Wu Xiao, Zheng Jialei, Ou Yimei
Formato: Artigo
Idioma:English
Publicado em: De Gruyter 2020-10-01
Colecção:Open Medicine
Assuntos:
Acesso em linha:https://doi.org/10.1515/med-2020-0157